Hughes Software Q1 results on July 10, 2001

A meeting of the Board of Directors of Hughes Software Systems Ltd is scheduled to be held on July 10, 2001 in USA to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2001.

Rallis Board approves disposal of Andheri, Mumbai land for Rs 1330 million

The Board of Directors of Rallis India Ltd at its meeting held today (July 3, 2001) has approved the disposal of surplus land situated at Suren Road, Andheri (East) Mumbai - 400 093 owned by the Company, subject to obtaining the clearances from all the authorities concerned. The value of the transaction, when completed, will be Rs 1330 million. The property is being acquired by Tata Sons Ltd/its subsidiaries.

JB Chemicals - negotiating overseas for exploitation of its two US Patents

In a communication issued to the BSE, JB Chemicals & Pharmaceuticals Ltd has informed that the Company's two Directors Mr. S.B.Mody and Mr. D.D. Chopra, who had been abroad to explore the options for exploiting the hidden values of two Patents in USA have found a positive response during their discussion overseas. On their return, Mr. S.B. Mody Whole Time Director- Marketing confirmed that their discussions overseas has been very encouraging and there are various options available to the Company, one of the them being a strong possibility to enter into a strategic alliance/joint venture abroad. This could be a stepping stone for the Company to exploit some of the other international Patents granted to the Company and also for some of those applications for which approval are pending. The Company has been granted number of Patents internationally on Novel Drug Delivery System (NDDS), the most significant being Ranitidine Controlled Release Formulations and Mertogyl Dental Gel in USA. The Company had recently filed Patent application for New Chemical Entities (NCE) with United States Patent & Trademark Office. The New Chemical Entities have a potent anti-inflammatory action. The Company has also filed Patent applications in USA and South Africa for Novel Compounds having potent therapeutic activities. The Patent application claims that the Company has invented Novel Compounds as well as process for their manufacture. Preclinical animal screening of these compounds has shown promising results for their use in inflammatory Joint Disorders. The Company intends to continue to file internationally Patents for NDDS, Bulk Drugs and its new R & D Research findings.

Infosys Board to consider US GAAP results along with Indian GAAP results

Infosys Technologies Ltd has informed BSE that the Board of Directors of the Company that is scheduled to meet on July 10, 2001 will consider and take on record among other things, the following items of agenda: 1. The unaudited financial results as per US GAAP for the first quarter ended June 30, 2001. 2. The audited financial results as per Indian GAAP for the first quarter ended June 30, 2001.

ACC 3 month despatches for FY 2001-02 up by 4.92%

Associated Cement Companies Ltd (ACC) has informed BSE that the Cement despatches from April 2001 to June 2001 are at 30.50 lakh tonnes as compared to 29.07 lakh tonnes in the corresponding period last fiscal. The cement production from April 2001 to June 2001 is at 30.15 lakh tonnes as compared to 28.57 lakh tonnes in the same period last year. The production for the month of June 2001 is at 10.25 lakh tonnes as compared to 9.37 lakh tonnes in June 2000. The cement despatches for the month of June 2001 are at 10.40 lakh tonnes as compared to 9.53 lakh tonnes in June 2000.

Essar Oil FY-01 net down by 58.36%

Essar Oil Ltd has posted a net profit of Rs 104.30 million for the year ended March 31, 2001 as against Rs 250.50 million for the previous year. Total Income for FY-01 is lower at Rs 1891.70 million as compared to Rs 2619 million for the previous year ended March 31, 2000.

Crompton Greaves Q1 results on July 24, 2001

A meeting of the Board of Directors of Crompton Greaves Ltd is scheduled to be held on July 24, 2001 to consider and take on record the financial results for the quarter ended June 30, 2001.

GNFC Q1 results on July 21, 2001

A meeting of the Board of Directors of Gujarat Narmada Valley Fertilizers Co. Ltd is scheduled to be held on July 21, 2001 to take on record the Unaudited Financial Results for the first quarter ended June 30, 2001 in respect of financial year 2001-2002.

Cinevista Communications announces changes in Management Structure

Cinvista Communications Ltd has informed BSE that at the Board Meeting held on June 28, 2001, the Board of Directors of the Company has been reconstituted. The Board has appointed the following persons as 'Additional Directors': 1. Shri Talat Aziz - Non-executive Director 2. Shri Niranjan Shivdasani - Independent and Non-Executive Director 3. Smt. Sulochana Talreja - Independent and Non-Executive Director. The Company has also informed that the following directors have resigned from the Board of Directors of the Company : 1. Smt. Gurucharan Das, Non-Executive Director with effect from June 27, 2001. 2. Smt. Pamma Mehta, Whole-time Director and Director with effect from July 02, 2001. 3. Smt. Sunita Malhotra, Whole-time Director and Director with effect from July 02, 2001.

Sun Pharma Q1 results on July 30, 2001

A meeting of Board of Directors of Sun Pharmaceuticals Industries Ltd is scheduled to be held on July 30, 2001 to take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2001. The aforesaid meeting will also consider payment of Interim Dividend on Equity Shares for the year ended March 31, 2001.

ACC Q1 results on July 12, 2001

A meeting of the Board of Directors of Associated Cement Companies Ltd is scheduled to be held on July 12, 2001 to consider and take on record the Unaudited Financial Results (provisional) for the quarter ended June 30, 2001.

Bharat Electronics announces 40% Dividend

The Board of Directors of Bharat Electronics Ltd at its meeting held on July 02, 2001 has decided to recommended a Dividend of 40% (i.e. Rs 4 per share of Rs 10 each) as against 25% paid in the previous year.

Satnam Overseas sets up wholly owned subsidiary in USA

Satnam Overseas Ltd has informed BSE that the Company has set up a wholly owned subsidiary in USA to cater to the markets of USA and nearby countries more aggressively.

UTI Bank clarifies on news item

With reference to the news article appearing in a leading financial daily titled "UTI Bank in talks to sell 20% equity" UTI Bank Ltd, in a communication issued to the BSE has informed that the Bank is in discussion with a number of investors for raising additional equity capital, but so far no decisions have been taken in this matter.

DCM Shriram Consolidated approves investment of equity stake in DSEL

DCM Shriram Consolidated Ltd has informed BSE that the Company has approved investment in equity shares of DCM Shriram Exports Ltd. (DSEL) as a result of which DSEL will become a subsidiary of the Company.

Amtek India Board allots shares on preferential basis

Amtek India Ltd has informed BSE that the Board of Directors of the Company has allotted 2.60 million equity shares of Rs 10 each at a premium of Rs 65 per share to promoters and their friends, relatives, associates and associated companies by way of preferential offer on firm allotment basis.

Asian Hotels gets new Chairman

Asian Hotels Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 28, 2001 has unanimously elected Mr. R.K.Bhargava, Director as the Chairman of the Bank.

Money

Rapid Information on Stocks & Corporates

Tell us what you think of this report